FDA将于2026年12月10日举办FY 2027仿制药研究需求与机会信息说明会
FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2027 - 12/10/2026
美国FDA将于2026年12月10日9:00-10:30 ET通过Microsoft Teams举办FY 2027仿制药研究需求与机会虚拟信息说明会,面向有意依据GDUFA科学与研究优先计划申报研究提案的学术及研究机构人员。
Webcast | Virtual
Event Title
FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2027
- Date:
- December 10, 2026
- Time:
- 9:00 a.m. - 10:30 a.m. ET
The U.S. Food and Drug Administration (FDA) is hosting a virtual Information Session on Generic Drug Research Needs & Opportunities for fiscal year (FY) 2027. This information session will be hosted virtually on Microsoft Teams.
Event Details
The goal of this session is to engage researchers in academia and other research organizations who may be interested in developing research proposals that align with the GDUFA Science and Research Priority Initiatives for FY 2027.
During the information session, FDA scientists will:
- Describe FY 2027 research needs and opportunities in selected GDUFA priority areas
- Explain how specific research would accelerate and expand patient access to high-quality, safe, and effective generic medicines
Following the brief presentations, attendees will:
- Have an opportunity to unmute and ask questions
- Clarify scientific aspects of the research
- Clarify procedures to submit a proposal for funding consideration
Proposals for research projects in these areas may be submitted in response to the FDA’s FY 2027 Broad Agency Announcement (BAA), under Part I: Generic Drugs. To be considered for FY 2027 funding, BAA research proposals must be received by Jan 22, 2027 at 5:00 PM EST.
Intended Audience
- Researchers who may be interested in developing BAA research proposals aligned with FDA’s FY 2027 GDUFA research priorities would likely find this information session helpful.
Questions
- Please submit questions about the information session or GDUFA research needs to GDUFARegulatoryScience@fda.hhs.gov.
来源:FDA 官方药品与生物制品信息 · fda.gov